PET-MRI Hybrid Enables New Approaches for Neuro-Imaging Scans
By MedImaging International staff writers Posted on 11 Apr 2017 |
Hybrid imaging techniques that combine Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) make use of the detailed images of human anatomy that MRI can provide, together with assessments of tissue function characteristics provided by PET imaging.
The new PET-MRI technique and other advanced neuro-imaging modalities, intended for the early diagnosis of conditions such as dementia and stroke are being displayed at the RadiologyAsia 2017 conference. The conference will host advanced medical imaging experts, and is taking place on May 19-20, 2017. The conference theme is “Bringing state-of-the-art imaging into clinical practice.”
The occurrence of dementia among an aging population is on the rise, and as the disease progresses it can result in ever increasing neuro-degenerative problems for patients. For this reason, early diagnosis is critical for improved patient outcomes.
The new PET-MRI technology provides both volumetric imaging information, as well as metabolic data for the diagnosis of early dementia. PET-MRI and the other new imaging techniques are already enabling clinical researchers to evaluate new drug therapies in clinical trials, and treat dementia and other conditions early, before they result in significant morbidity.
The new PET-MRI technique and other advanced neuro-imaging modalities, intended for the early diagnosis of conditions such as dementia and stroke are being displayed at the RadiologyAsia 2017 conference. The conference will host advanced medical imaging experts, and is taking place on May 19-20, 2017. The conference theme is “Bringing state-of-the-art imaging into clinical practice.”
The occurrence of dementia among an aging population is on the rise, and as the disease progresses it can result in ever increasing neuro-degenerative problems for patients. For this reason, early diagnosis is critical for improved patient outcomes.
The new PET-MRI technology provides both volumetric imaging information, as well as metabolic data for the diagnosis of early dementia. PET-MRI and the other new imaging techniques are already enabling clinical researchers to evaluate new drug therapies in clinical trials, and treat dementia and other conditions early, before they result in significant morbidity.
Latest Nuclear Medicine News
- New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment
- Low-Dose Radiation Therapy Demonstrates Potential for Treatment of Heart Failure